Johnson & Johnson today launched the Dual Control campaign in Asia Pacific to raise awareness about the importance of ...
The complete blood count routine test provides a snapshot of your body's blood production and immunity. The test measures a variety of components in your blood, including red blood cells, white blood ...
The FDA has approved golimumab for the treatment of children with moderately to severely active ulcerative colitis who weigh ...
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement and 30.2% achieving clinical remission at the highest dose ...
Johnson & Johnson (NYSE: JNJ) today announced additional Week 12 results from the Phase 2b ANTHEM-UC study of icotrokinra, a first-in-class investigational targeted oral peptide that selectively ...
Everyday Health on MSN
Ulcerative Colitis Can Raise Your Risk of Cancer. Here’s What to Know — and Do — About It
Ulcerative colitis and colorectal cancer have a connection, but you can lower your risk of the latter through regular cancer ...
CAR T-cell therapy was first developed as a lymphoma treatment but has recently been applied to autoimmune diseases, primarily lupus, systemic sclerosis, and myositis. Up to this point, ulcerative ...
Everyday Health on MSN
How to Protect Against Blood Clots if You Have Ulcerative Colitis
People with inflammatory bowel disease, like ulcerative colitis, are 2 to 3 times more likely to develop blood clots than ...
The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. With ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately ...
EMA opinion supports expanded use of TREMFYA in phase 3 UC treatment Johnson & Johnson has announced a positive opinion from the CHMP recommending expanded marketing authorisation for TREMFYA ...
DE PERE, Wis. (WFRV) – Community members gathered at Voyageur Park for a walk event to raise money for research and support those with Crohn’s Disease or ulcerative colitis. Community in Wisconsin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback